Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years-Reference-Cited by-同舟云学术

Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years

Published:2019-08 Issue: Volume:168 Page:61-67
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Surana Pallavi,Kapuria Devika,Broadwell Carly,Wright Elizabeth C.,Takyar Varun,Kleiner David E.,Ghany Marc G.,Ben-Yakov Gil,Heller Theo,Liang T. Jake,Koh Christopher

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference35 articles.

1. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results;Başar;Clin. Res. Hepatol. Gastroenterol.,2013

2. Non-invasive assessment of liver fibrosis in chronic hepatitis B;Branchi;World J. Gastroenterol.,2014

3. Liver biopsy;Bravo;N. Engl. J. Med.,2001

4. Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years;Buti;Hepatol. Int.l,2015

5. Hepatitis B: are non-invasive markers of liver fibrosis reliable?;Castera;Liver Int.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-2-Binding Protein Glycosylation Isomer (M2BPGi) and AGAP Score as Markers of Noninvasive Test for Liver Fibrosis versus FibroScan in Chronic Hepatitis B Patients: A Retrospective Observational Study;International Journal of Hepatology;2024-05-29

2. Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments;Hepatology International;2024-04-02

3. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

4. Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis;Frontiers in Public Health;2022-11-03

5. Long‐term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B;Journal of Gastroenterology and Hepatology;2021-09-14